ImmuCell Corporation
ICCC | NASDAQ
$10.26
-$0.06 (-0.58%)
At close: Oct 30, 2026, 4:00 PM ET
$10.26
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -51.25 | -19.81 | -6.79 | -19.06 | -776.71 | -42.50 |
PEG Ratio | 0.95 | 0.30 | -0.05 | -0.01 | 8.38 | 1.62 |
PS Ratio | 2.01 | 1.59 | 2.24 | 2.54 | 3.16 | 2.80 |
PB Ratio | 2.05 | 1.53 | 1.57 | 1.56 | 1.86 | 1.52 |
P/FCF Ratio | 45.32 | -390.09 | -5.97 | -8.56 | -36.71 | -15.57 |
P/OCF Ratio | 22.43 | 117.52 | -8.38 | -30.60 | 63.66 | 32.62 |
OCF/S Ratio | 8.95 | 1.35 | -26.75 | -8.31 | 4.96 | 8.57 |
Debt / Equity Ratio | 0.49 | 0.55 | 0.67 | 0.41 | 0.32 | 0.38 |
Quick Ratio | 1.93 | 1.80 | 0.87 | 2.59 | 5.20 | 4.55 |
Current Ratio | 4.26 | 3.41 | 2.73 | 4.56 | 6.42 | 5.50 |
Asset Turnover | 0.65 | 0.59 | 0.40 | 0.41 | 0.43 | 0.38 |
Interest Coverage | 3.76 | -2.88 | -12.69 | -6.60 | 0.82 | -3.34 |
Return on Equity | -3.84% | -7.84% | -23.10% | -8.21% | -0.24% | -3.62% |
Return on Assets | -2.45% | -4.78% | -13.18% | -5.56% | -0.18% | -2.53% |
Return on Invested Capital | 4.10% | -3.85% | -13.79% | -5.36% | 0.60% | -3.50% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 41.40% | 29.97% | 25.16% | 41.19% | 44.98% | 44.73% |
Net Profit Margin | -3.76% | -8.14% | -33.05% | -13.43% | -0.41% | -6.66% |
Pretax Profit Margin | -3.72% | -8.10% | -33.02% | -13.39% | -0.36% | -6.73% |
Operating Profit Margin | 5.97% | -6.19% | -32.90% | -12.38% | 1.34% | -8.99% |
FCF Margin | 4.43% | -0.41% | -37.59% | -29.72% | -8.60% | -17.97% |
EBITDA Margin | 7.74% | 4.03% | -14.33% | 1.88% | 14.02% | 10.74% |
Add to Watchlist
Select watchlists to add or remove ICCC